Globus Medical (GMED) Free Cash Flow (2011 - 2026)

Globus Medical has reported Free Cash Flow for 16 years, with the latest figure at $162.7 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 15.26% year-over-year to $162.7 million; the trailing twelve-month figure through Mar 2026 stood at $610.3 million (up 22.2% YoY), and the FY2025 full-year result was $588.8 million, up 45.3% from the prior year.
• Free Cash Flow for Q1 2026 stood at $162.7 million, up from $97.4 million in the prior quarter.
• The five-year high for Free Cash Flow was $318.9 million in Q3 2025, with the low at -$17.8 million in Q3 2022.
• Historically, Free Cash Flow has averaged $87.8 million across 5 years, with a median of $47.0 million in 2024.
• Annual changes were most pronounced in 2022 — Free Cash Flow sank 122.98% — and 2024, when it surged 35283.37%.
• Globus Medical's Free Cash Flow stood at $112.3 million in 2022, then decreased by 27.14% to $81.8 million in 2023, then surged by 136.24% to $193.2 million in 2024, then plunged by 49.61% to $97.4 million in 2025, then soared by 67.16% to $162.7 million in 2026.
• The last three Free Cash Flow figures came in at $162.7 million (Q1 2026), $97.4 million (Q4 2025), and $318.9 million (Q3 2025), per Business Quant data.